
A analysis group has developed an progressive nanomotor-based technique to enhance immunotherapy for bladder most cancers. The examine, revealed within the journal Nature Communications, affords a promising different to the constraints of current remedies. The analysis was led by the Institute for Bioengineering of Catalonia (IBEC) and Pohang College of Science and Know-how (POSTECH) in South Korea.
At this time, the standard remedy for non-invasive bladder most cancers is immunotherapy with BCG (Bacillus Calmette-Guérin), a weakened bacterium that’s launched into the bladder to stimulate an immune response in opposition to tumor cells.
Nonetheless, this remedy has essential limitations, corresponding to the necessity for a number of administrations, extreme unintended effects and decreased efficacy in sure sufferers. The brand new nanomotor-based remedy affords a more practical different, activating the immune system extra effectively and considerably lowering tumor progress in preclinical mouse fashions.
These nanomotors are self-propelled nanoparticles that use the enzyme urease to react with urea in urine. This skill to maneuver permits them to be distributed extra effectively within the bladder, reaching tumor cells extra exactly and prolonging the drug’s time within the affected tissue.
The nanomotors keep it up their floor a STING agonist, a key molecule within the activation of the immune system. “Now we have proven that our method is more practical than standard BCG remedy in mice, which is a breakthrough in immunotherapy for this sort of most cancers,” explains Samuel Sánchez, ICREA Analysis Professor at IBEC and co-leader of the examine.
To additional enhance the immune response, the researchers mixed the nanomotors with a PD-1 inhibitor, a remedy that blocks an escape mechanism utilized by tumor cells.

“The mix of our nanomotors with the anti-PD-1 remedy confirmed a outstanding synergy that might result in more practical mixture therapies with fewer unintended effects,” provides Sánchez.
The examine represents an essential advance within the seek for new therapeutic methods for bladder most cancers, a illness with a excessive recurrence price that requires aggressive and extended remedy.
PHI BIOMED Co., Seoul Nationwide College, Seoul Nationwide College Hospital, CIC biomaGUNE of the Basque Nation and the Korea Superior Institute of Science and Know-how (KAIST) participated on this work.
Extra info:
Hyunsik Choi et al, Urease-powered nanomotor containing STING agonist for bladder most cancers immunotherapy, Nature Communications (2024). DOI: 10.1038/s41467-024-54293-z
Offered by
Institute for Bioengineering of Catalonia (IBEC)
Quotation:
Novel nanomotors may enhance bladder most cancers immunotherapy (2025, February 27)
retrieved 27 February 2025
from https://phys.org/information/2025-02-nanomotors-bladder-cancer-immunotherapy.html
This doc is topic to copyright. Aside from any truthful dealing for the aim of personal examine or analysis, no
half could also be reproduced with out the written permission. The content material is supplied for info functions solely.
